🎗️ OncologyTablet
Truqap
Capivasertib
AKT inhibitor for HR-positive, HER2-negative advanced breast cancer with AKT/PIK3CA/PTEN alterations.
Form
Tablet
Uses
1
Side effects
6
Category
Oncology
01
What is Truqap used for?
- HR+/HER2- advanced breast cancer (with fulvestrant)
02
Capivasertib side effects
Common side effects of Capivasertib include:
Diarrhea
Rash
Nausea
Hyperglycemia
Fatigue
Stomatitis
CommonModerateLess common
03
Capivasertib warnings & precautions
- Hyperglycemia management required
- Rash management may require dose modification
- Embryo-fetal toxicity
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Truqap in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.